Drop-free approaches for cataract surgery
PURPOSE OF REVIEWRoutine prophylaxis for adverse events following cataract surgery is evolving. Prior reliance on topical eyedrop instillation by patients is giving way to surgeon directed injections at the time of cataract surgery. The benefit of this new approach is assured delivery of drugs in st...
Gespeichert in:
| Veröffentlicht in: | Current opinion in ophthalmology 2020-01, Vol.31 (1), p.67-73 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 73 |
|---|---|
| container_issue | 1 |
| container_start_page | 67 |
| container_title | Current opinion in ophthalmology |
| container_volume | 31 |
| creator | Shorstein, Neal H. Myers, William G. |
| description | PURPOSE OF REVIEWRoutine prophylaxis for adverse events following cataract surgery is evolving. Prior reliance on topical eyedrop instillation by patients is giving way to surgeon directed injections at the time of cataract surgery. The benefit of this new approach is assured delivery of drugs in standardized doses which should optimize the healing process and reduce the incidence of untoward events with higher confidence.
RECENT FINDINGSAdoption rates of intracameral antibiotic injection amongst European and American cataract surgeons is increasing. Techniques to inject periocular corticosteroid for routine inflammation prophylaxis are also in development. In combination with intraoperative pharmacologic dilation, a drop-free modality can be achieved.
SUMMARYIntraoperative injections offer the patient and surgeon assured drug delivery and hold promise to avoid the pitfalls of patient adherence, incorrect topical instillation, and topical drop-associated corneal issues. |
| doi_str_mv | 10.1097/ICU.0000000000000625 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_wolte</sourceid><recordid>TN_cdi_proquest_miscellaneous_2312280737</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2312280737</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4475-2c52d914a1bb1f6a47973b61051ad675dcb2777fd04060fbb5508ed9d114bd9e3</originalsourceid><addsrcrecordid>eNqNkVtLxDAQhYMo3v-ByD4qUs3k0qSPUq8g-OI-lySdutXuZk1aFv-9WVYX8UHNS2bgO3MmJ4QcAT0HWqiL-3J8Tr-fnMkNsguSQ6Yog81UU0EzrbjeIXsxviRGUC23yQ6HXGvG8l1yehX8PGsC4sjM58EbN8E4anwYOdObYFw_ikN4xvB-QLYa00U8_Lz3yfjm-qm8yx4eb-_Ly4fMCaFkxpxkdQHCgLXQ5EaoQnGbA5Vg6lzJ2lmmlGrqtEtOG2ulpBrrogYQti6Q75OT1dy0zduAsa-mbXTYdWaGfogV48CYpoqrhIoV6oKPMWBTzUM7NeG9AlotQ6pSSNXPkJLs-NNhsFOs16KvVBJwtgIWaH0TXYszh2ssTZE550xDqgASrf9Pl21v-tbPSj_M-m9S3_UY4ms3LDBUEzRdP_nrEeIX6dJVKp6-g7Jkm9psac_4BwbnoU4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2312280737</pqid></control><display><type>article</type><title>Drop-free approaches for cataract surgery</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><creator>Shorstein, Neal H. ; Myers, William G.</creator><creatorcontrib>Shorstein, Neal H. ; Myers, William G.</creatorcontrib><description>PURPOSE OF REVIEWRoutine prophylaxis for adverse events following cataract surgery is evolving. Prior reliance on topical eyedrop instillation by patients is giving way to surgeon directed injections at the time of cataract surgery. The benefit of this new approach is assured delivery of drugs in standardized doses which should optimize the healing process and reduce the incidence of untoward events with higher confidence.
RECENT FINDINGSAdoption rates of intracameral antibiotic injection amongst European and American cataract surgeons is increasing. Techniques to inject periocular corticosteroid for routine inflammation prophylaxis are also in development. In combination with intraoperative pharmacologic dilation, a drop-free modality can be achieved.
SUMMARYIntraoperative injections offer the patient and surgeon assured drug delivery and hold promise to avoid the pitfalls of patient adherence, incorrect topical instillation, and topical drop-associated corneal issues.</description><identifier>ISSN: 1040-8738</identifier><identifier>EISSN: 1531-7021</identifier><identifier>DOI: 10.1097/ICU.0000000000000625</identifier><identifier>PMID: 31688226</identifier><language>eng</language><publisher>PHILADELPHIA: Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Antibiotic Prophylaxis ; Cataract Extraction ; Endophthalmitis - prevention & control ; Humans ; Life Sciences & Biomedicine ; Ophthalmic Solutions - therapeutic use ; Ophthalmology ; Postoperative Complications - prevention & control ; Science & Technology</subject><ispartof>Current opinion in ophthalmology, 2020-01, Vol.31 (1), p.67-73</ispartof><rights>Wolters Kluwer Health, Inc. All rights reserved.</rights><rights>Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>24</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000563328100011</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c4475-2c52d914a1bb1f6a47973b61051ad675dcb2777fd04060fbb5508ed9d114bd9e3</citedby><cites>FETCH-LOGICAL-c4475-2c52d914a1bb1f6a47973b61051ad675dcb2777fd04060fbb5508ed9d114bd9e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930,28253</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31688226$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shorstein, Neal H.</creatorcontrib><creatorcontrib>Myers, William G.</creatorcontrib><title>Drop-free approaches for cataract surgery</title><title>Current opinion in ophthalmology</title><addtitle>CURR OPIN OPHTHALMOL</addtitle><addtitle>Curr Opin Ophthalmol</addtitle><description>PURPOSE OF REVIEWRoutine prophylaxis for adverse events following cataract surgery is evolving. Prior reliance on topical eyedrop instillation by patients is giving way to surgeon directed injections at the time of cataract surgery. The benefit of this new approach is assured delivery of drugs in standardized doses which should optimize the healing process and reduce the incidence of untoward events with higher confidence.
RECENT FINDINGSAdoption rates of intracameral antibiotic injection amongst European and American cataract surgeons is increasing. Techniques to inject periocular corticosteroid for routine inflammation prophylaxis are also in development. In combination with intraoperative pharmacologic dilation, a drop-free modality can be achieved.
SUMMARYIntraoperative injections offer the patient and surgeon assured drug delivery and hold promise to avoid the pitfalls of patient adherence, incorrect topical instillation, and topical drop-associated corneal issues.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotic Prophylaxis</subject><subject>Cataract Extraction</subject><subject>Endophthalmitis - prevention & control</subject><subject>Humans</subject><subject>Life Sciences & Biomedicine</subject><subject>Ophthalmic Solutions - therapeutic use</subject><subject>Ophthalmology</subject><subject>Postoperative Complications - prevention & control</subject><subject>Science & Technology</subject><issn>1040-8738</issn><issn>1531-7021</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>EIF</sourceid><recordid>eNqNkVtLxDAQhYMo3v-ByD4qUs3k0qSPUq8g-OI-lySdutXuZk1aFv-9WVYX8UHNS2bgO3MmJ4QcAT0HWqiL-3J8Tr-fnMkNsguSQ6Yog81UU0EzrbjeIXsxviRGUC23yQ6HXGvG8l1yehX8PGsC4sjM58EbN8E4anwYOdObYFw_ikN4xvB-QLYa00U8_Lz3yfjm-qm8yx4eb-_Ly4fMCaFkxpxkdQHCgLXQ5EaoQnGbA5Vg6lzJ2lmmlGrqtEtOG2ulpBrrogYQti6Q75OT1dy0zduAsa-mbXTYdWaGfogV48CYpoqrhIoV6oKPMWBTzUM7NeG9AlotQ6pSSNXPkJLs-NNhsFOs16KvVBJwtgIWaH0TXYszh2ssTZE550xDqgASrf9Pl21v-tbPSj_M-m9S3_UY4ms3LDBUEzRdP_nrEeIX6dJVKp6-g7Jkm9psac_4BwbnoU4</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Shorstein, Neal H.</creator><creator>Myers, William G.</creator><general>Wolters Kluwer Health, Inc. All rights reserved</general><general>Copyright Wolters Kluwer Health, Inc. All rights reserved</general><general>Lippincott Williams & Wilkins</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200101</creationdate><title>Drop-free approaches for cataract surgery</title><author>Shorstein, Neal H. ; Myers, William G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4475-2c52d914a1bb1f6a47973b61051ad675dcb2777fd04060fbb5508ed9d114bd9e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotic Prophylaxis</topic><topic>Cataract Extraction</topic><topic>Endophthalmitis - prevention & control</topic><topic>Humans</topic><topic>Life Sciences & Biomedicine</topic><topic>Ophthalmic Solutions - therapeutic use</topic><topic>Ophthalmology</topic><topic>Postoperative Complications - prevention & control</topic><topic>Science & Technology</topic><toplevel>online_resources</toplevel><creatorcontrib>Shorstein, Neal H.</creatorcontrib><creatorcontrib>Myers, William G.</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shorstein, Neal H.</au><au>Myers, William G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drop-free approaches for cataract surgery</atitle><jtitle>Current opinion in ophthalmology</jtitle><stitle>CURR OPIN OPHTHALMOL</stitle><addtitle>Curr Opin Ophthalmol</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>31</volume><issue>1</issue><spage>67</spage><epage>73</epage><pages>67-73</pages><issn>1040-8738</issn><eissn>1531-7021</eissn><abstract>PURPOSE OF REVIEWRoutine prophylaxis for adverse events following cataract surgery is evolving. Prior reliance on topical eyedrop instillation by patients is giving way to surgeon directed injections at the time of cataract surgery. The benefit of this new approach is assured delivery of drugs in standardized doses which should optimize the healing process and reduce the incidence of untoward events with higher confidence.
RECENT FINDINGSAdoption rates of intracameral antibiotic injection amongst European and American cataract surgeons is increasing. Techniques to inject periocular corticosteroid for routine inflammation prophylaxis are also in development. In combination with intraoperative pharmacologic dilation, a drop-free modality can be achieved.
SUMMARYIntraoperative injections offer the patient and surgeon assured drug delivery and hold promise to avoid the pitfalls of patient adherence, incorrect topical instillation, and topical drop-associated corneal issues.</abstract><cop>PHILADELPHIA</cop><pub>Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>31688226</pmid><doi>10.1097/ICU.0000000000000625</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1040-8738 |
| ispartof | Current opinion in ophthalmology, 2020-01, Vol.31 (1), p.67-73 |
| issn | 1040-8738 1531-7021 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2312280737 |
| source | MEDLINE; Journals@Ovid Complete; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /> |
| subjects | Anti-Bacterial Agents - therapeutic use Antibiotic Prophylaxis Cataract Extraction Endophthalmitis - prevention & control Humans Life Sciences & Biomedicine Ophthalmic Solutions - therapeutic use Ophthalmology Postoperative Complications - prevention & control Science & Technology |
| title | Drop-free approaches for cataract surgery |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T21%3A49%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_wolte&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drop-free%20approaches%20for%20cataract%20surgery&rft.jtitle=Current%20opinion%20in%20ophthalmology&rft.au=Shorstein,%20Neal%20H.&rft.date=2020-01-01&rft.volume=31&rft.issue=1&rft.spage=67&rft.epage=73&rft.pages=67-73&rft.issn=1040-8738&rft.eissn=1531-7021&rft_id=info:doi/10.1097/ICU.0000000000000625&rft_dat=%3Cproquest_wolte%3E2312280737%3C/proquest_wolte%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2312280737&rft_id=info:pmid/31688226&rfr_iscdi=true |